Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J N Cohn

Showing results (71-80 of 410) with videos related to

Pageof 41
Sort By:
The Medical Clinics of North America|July 1, 1975
Hepatocirculatory failureJ N Cohn
Heart Disease (Hagerstown, Md.)|December 1, 2001
ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implicationsJ N Cohn
Journal of Cardiac Failure|January 10, 2002
Looking back and looking forwardJ N Cohn
American Journal of Hypertension|August 11, 2001
Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision makingJ N Cohn
The American Journal of Cardiology|October 2, 1990
Mechanisms in heart failure and the role of angiotensin-converting enzyme inhibitionJ N Cohn
Journal of Cardiac Failure|September 19, 2001
The surrogate specialist: essential but inadequateJ N Cohn
The American Journal of Cardiology|April 7, 1994
Has the problem of heart failure been solved?J N Cohn
Cardiovascular Drugs and Therapy|February 1, 1994
Treatment of infarct related heart failure: vasodilators other than ACE inhibitorsJ N Cohn
The Medical Annals of the District of Columbia|March 1, 1970
Treatment of shock following myocardial infarctionJ N Cohn
Clinical Cardiology|March 1, 1995
Plasma norepinephrine and mortalityJ N Cohn
Pageof 41

Showing results (71-80 of 410) with videos related to

Sort By:
Pageof 41
The Medical Clinics of North America|July 1, 1975
Hepatocirculatory failureJ N Cohn
Heart Disease (Hagerstown, Md.)|December 1, 2001
ACE inhibition and vascular remodeling of resistance vessels: vascular compliance and cardiovascular implicationsJ N Cohn
Journal of Cardiac Failure|January 10, 2002
Looking back and looking forwardJ N Cohn
American Journal of Hypertension|August 11, 2001
Arterial compliance to stratify cardiovascular risk: more precision in therapeutic decision makingJ N Cohn
The American Journal of Cardiology|October 2, 1990
Mechanisms in heart failure and the role of angiotensin-converting enzyme inhibitionJ N Cohn
Journal of Cardiac Failure|September 19, 2001
The surrogate specialist: essential but inadequateJ N Cohn
The American Journal of Cardiology|April 7, 1994
Has the problem of heart failure been solved?J N Cohn
Cardiovascular Drugs and Therapy|February 1, 1994
Treatment of infarct related heart failure: vasodilators other than ACE inhibitorsJ N Cohn
The Medical Annals of the District of Columbia|March 1, 1970
Treatment of shock following myocardial infarctionJ N Cohn
Clinical Cardiology|March 1, 1995
Plasma norepinephrine and mortalityJ N Cohn
Pageof 41